InterMune starts Phase II with Actimmune

InterMune Pharmaceuticals (Palo Alto, Calif.) started a Phase II trial of Actimmune interferon gamma-1b to treat cryptococcal meningitis. The U.S. and Peru-based trial will enroll about 60 patients. ...